| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |